Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (9525)	11/20/2003 12:23:25 PM
From: Biomaven	Respond to of 52153

this type of very localized bladder cancer is very special and that a high degree of complete responses should be expected. The following site has some good info and links. blcwebcafe.org About 50k cases a year of bladder cancer, of which 80% are superficial. Here's a quote I found in a link from that site: Schellhammer: Dr. Herr, please describe your practice regarding immediate intravesical therapy [instilling chemo into bladder - Peter] and your preferred agent. Herr: We do not use intravesical therapy immediately after resection. It is of value for low-grade papillary tumors as shown in randomized trials, but the benefit is relatively short-lived, and the vast majority of patients experience a recurrence over time. Follow-up cystoscopy still needs to be done at frequent intervals, and small recurrent papillary tumors are often fulgurated in the office at the time of flexible cystoscopy. A formal resection under anesthesia is not necessary in most cases that might benefit from immediate intravesical therapy. (Note that the other doctors asked all use immediate intravesical therapy) conturo.com So maybe there is a pretty decent potential market here for such a small company. Peter